| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 148, 865-875, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
SV Litvinov, W van Driel, CM van Rhijn, HA Bakker, H van Krieken, GJ Fleuren and SO Warnaar
Department of Pathology, Leiden University, The Netherlands.
Ep-CAM, an epithelial adhesion molecule, is absent in normal squamous epithelia but can be detected in some squamous carcinomas. Using a panel of monoclonal antibodies to keratinocyte differentiation and proliferation markers, we investigated the association of EP-CAM expression with differentiation-related and/or neoplastic changes in cervical epithelium. Normal endocervical glandular epithelium (Both columnar and reserve cells) appeared strongly positive for EP-CAM, whereas ectocervical squamous epithelial cells did not express this molecule. Expression of Ep-CAM (in basal cells) was sometimes observed in morphologically normal ectocervical tissue but only in areas bordering cervical intraepithelial neoplasia (CIN) lesions. At the early stages of neoplasia the expression of Ep-CAM was regularly present in squamous epithelium, in general consistent with the areas of atypical, undifferentiated cells. Thus, in CIN grades I and II, the basal/suprabasal layers of the epithelia were positive, whereas in CIN grade III lesions, up to 100% of the cells over the whole thickness of the epithelium sometimes excluding the very upper layers, expressed Ep- CAM. A clear increase, not only in number of positive cells but also in levels of Ep-CAM expression (intensity) was observed during progression from CIN I to CIN III. Expression of Ep-CAM in ectocervical lesions did not coincide with a reappearance of the simple epithelium cytokeratins (CK8 and CK18). On the other hand, expression of Ep-CAM in atypical cells of CIN lesions correlated with the disappearance of CK13, which normally marks cells undergoing squamous differentiation. As was shown with Ki-67, a marker for proliferating cell populations, the areas of Ep-CAM expression were also the areas of enhanced proliferation. Cells expressing Ep-CAM did not express involucrin, a marker for cells committed to terminal differentiation. In the majority of both squamous and adenocarcinomas of the cervix a strong expression of Ep-CAM was observed, although some decrease in the expression (both the intensity and the number of positive cells), as compared with CIN III lesions, was observed in the areas of squamous differentiation. This study demonstrates that the expression of Ep-CAM in cervical squamous epithelium is associated with abnormal proliferation of cell populations that are not committed to terminal differentiation.
This article has been cited by other articles:
 |
|
 |
|
  A Brunner, M Prelog, I Verdorfer, A Tzankov, G Mikuz, and C Ensinger EpCAM is predominantly expressed in high grade and advanced stage urothelial carcinoma of the bladder J. Clin. Pathol., March 1, 2008; 61(3): 307 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Fong, M Steurer, P Obrist, V Barbieri, R Margreiter, A Amberger, K Laimer, G Gastl, A Tzankov, and G Spizzo Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance J. Clin. Pathol., January 1, 2008; 61(1): 31 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Trzpis, P. M.J. McLaughlin, L. M.F.H. de Leij, and M. C. Harmsen Epithelial Cell Adhesion Molecule: More than a Carcinoma Marker and Adhesion Molecule Am. J. Pathol., August 1, 2007; 171(2): 386 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Frederick, B. A. Helfrich, C. D. Coldren, D. Zheng, D. Chan, P. A. Bunn Jr., and D. Raben Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma Mol. Cancer Ther., June 1, 2007; 6(6): 1683 - 1691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N A C S Wong, B F Warren, J Piris, N Maynard, R Marshall, and W F Bodmer EpCAM and gpA33 are markers of Barrett's metaplasia J. Clin. Pathol., March 1, 2006; 59(3): 260 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Tsai, R. Herrera-Goepfert, R. J. Tibshirani, S. Yang, A. Mohar, J. Guarner, and J. Parsonnet Changes of Gene Expression in Gastric Preneoplasia following Helicobacter pylori Eradication Therapy. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 272 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. de Bono, A. W. Tolcher, A. Forero, G. F. A. Vanhove, C. Takimoto, R. J. Bauer, L. A. Hammond, A. Patnaik, M. L. White, S. Shen, et al. ING-1, a Monoclonal Antibody Targeting Ep-CAM in Patients with Advanced Adenocarcinomas Clin. Cancer Res., November 15, 2004; 10(22): 7555 - 7565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. A. Osta, Y. Chen, K. Mikhitarian, M. Mitas, M. Salem, Y. A. Hannun, D. J. Cole, and W. E. Gillanders EpCAM Is Overexpressed in Breast Cancer and Is a Potential Target for Breast Cancer Gene Therapy Cancer Res., August 15, 2004; 64(16): 5818 - 5824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Varga, P. Obrist, S. Schneeberger, G. Muhlmann, C. Felgel-Farnholz, D. Fong, M. Zitt, T. Brunhuber, G. Schafer, G. Gastl, et al. Overexpression of Epithelial Cell Adhesion Molecule Antigen in Gallbladder Carcinoma Is an Independent Marker for Poor Survival Clin. Cancer Res., May 1, 2004; 10(9): 3131 - 3136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Seligson, A. J. Pantuck, X. Liu, Y. Huang, S. Horvath, M. H. T. Bui, K.-r. Han, A. J. L. Correa, M. Eeva, S. Tze, et al. Epithelial Cell Adhesion Molecule (KSA) Expression: Pathobiology and Its Role as an Independent Predictor of Survival in Renal Cell Carcinoma Clin. Cancer Res., April 15, 2004; 10(8): 2659 - 2669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Szendefi, H. Walt, T. B. Krasieva, R. Caduff, K. E. Osann, and V. J. LaMorte Association Between Promyelocyte Protein and Small Ubiquitin-Like Modifier Protein and the Progression of Cervical Neoplasia Obstet. Gynecol., December 1, 2003; 102(6): 1269 - 1277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Winter, I. D. Nagtegaal, J. H. J. M. van Krieken, and S. V. Litvinov The Epithelial Cell Adhesion Molecule (Ep-CAM) as a Morphoregulatory Molecule Is a Tool in Surgical Pathology Am. J. Pathol., December 1, 2003; 163(6): 2139 - 2148. [Abstract] [Full Text]
|
|
|
|
|
|
J.-H. Kim, D. Herlyn, K.-k. Wong, D.-C. Park, J. O. Schorge, K. H. Lu, S. J. Skates, D. W. Cramer, R. S. Berkowitz, and S. C. Mok Identification of Epithelial Cell Adhesion Molecule Autoantibody in Patients with Ovarian Cancer Clin. Cancer Res., October 15, 2003; 9(13): 4782 - 4791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Di Paolo, J. Willuda, S. Kubetzko, I. Lauffer, D. Tschudi, R. Waibel, A. Pluckthun, R. A. Stahel, and U. Zangemeister-Wittke A Recombinant Immunotoxin Derived from a Humanized Epithelial Cell Adhesion Molecule-specific Single-Chain Antibody Fragment Has Potent and Selective Antitumor Activity Clin. Cancer Res., July 1, 2003; 9(7): 2837 - 2848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Monk, M. Cogan, J. C. Felix, N. M. Lonky, J. S. Bentz, C. J. Marshall, R. M. Cestero, L. R. Rowe, and S. A. Lonky A Stiff Bristled, Spiral-Shaped Ectocervical Brush: A Device for Transepithelial Tissue Biopsy Obstet. Gynecol., December 1, 2002; 100(6): 1276 - 1284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Trojan, M. Witzens, J. L. Schultze, R. H. Vonderheide, S. Harig, A. M. Krackhardt, R. A. Stahel, and J. G. Gribben Generation of Cytotoxic T Lymphocytes against Native and Altered Peptides of Human Leukocyte Antigen-A*0201 Restricted Epitopes from the Human Epithelial Cell Adhesion Molecule Cancer Res., June 1, 2001; 61(12): 4761 - 4765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. J. McLaughlin, M. C. Harmsen, W. H. A. Dokter, B.-J. Kroesen, H. van der Molen, M. G. L. Brinker, H. Hollema, M. H. J. Ruiters, C. H. C. M. Buys, and L. F. M. H. de Leij The Epithelial Glycoprotein 2 (EGP-2) Promoter-driven Epithelial-specific Expression of EGP-2 in Transgenic Mice: A New Model to Study Carcinoma-directed Immunotherapy Cancer Res., May 1, 2001; 61(10): 4105 - 4111. [Abstract] [Full Text]
|
|
|
|
|
|
C. J. de Boer, E. van Dorst, H. van Krieken, C. M. Jansen-van Rhijn, S. O. Warnaar, G. J. Fleuren, and S. V. Litvinov Changing Roles of Cadherins and Catenins during Progression of Squamous Intraepithelial Lesions in the Uterine Cervix Am. J. Pathol., August 1, 1999; 155(2): 505 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Balzar, H. A. M. Bakker, I. H. Briaire-de-Bruijn, G. J. Fleuren, S. O. Warnaar, and S. V. Litvinov Cytoplasmic Tail Regulates the Intercellular Adhesion Function of the Epithelial Cell Adhesion Molecule Mol. Cell. Biol., August 1, 1998; 18(8): 4833 - 4843. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. V. Litvinov, M. Balzar, M. J. Winter, H. A.M. Bakker, I. H. B.-d. Bruijn, F. Prins, G. J. Fleuren, and S. O. Warnaar Epithelial Cell Adhesion Molecule (Ep-CAM) Modulates Cell-Cell Interactions Mediated by Classic Cadherins J. Cell Biol., December 1, 1997; 139(5): 1337 - 1348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Trebak, G. E. Begg, J. M. Chong, E. V. Kanazireva, D. Herlyn, and D. W. Speicher Oligomeric State of the Colon Carcinoma-associated Glycoprotein GA733-2 (Ep-CAM/EGP40) and Its Role in GA733-mediated Homotypic Cell-Cell Adhesion J. Biol. Chem., January 12, 2001; 276(3): 2299 - 2309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Chong and D. W. Speicher Determination of Disulfide Bond Assignments and N-Glycosylation Sites of the Human Gastrointestinal Carcinoma Antigen GA733-2 (CO17-1A, EGP, KS1-4, KSA, and Ep-CAM) J. Biol. Chem., February 16, 2001; 276(8): 5804 - 5813. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
